D'AURIA, GIULIANA
 Distribuzione geografica
Continente #
NA - Nord America 409
EU - Europa 148
AS - Asia 34
AF - Africa 3
SA - Sud America 1
Totale 595
Nazione #
US - Stati Uniti d'America 409
UA - Ucraina 39
SE - Svezia 37
IT - Italia 35
IN - India 15
DE - Germania 12
CN - Cina 10
FI - Finlandia 10
SG - Singapore 9
IE - Irlanda 7
FR - Francia 2
TG - Togo 2
AR - Argentina 1
BG - Bulgaria 1
CH - Svizzera 1
EE - Estonia 1
GB - Regno Unito 1
MK - Macedonia 1
RO - Romania 1
SC - Seychelles 1
Totale 595
Città #
Fairfield 71
Woodbridge 61
Houston 46
Ashburn 28
Chandler 24
Cambridge 22
Seattle 18
Jacksonville 16
Ann Arbor 15
Wilmington 14
San Paolo di Civitate 12
Princeton 9
Boston 8
Lawrence 8
Beijing 7
Dublin 7
Milan 7
Plano 7
Andover 5
Fremont 5
Norwalk 4
Rome 4
Helsinki 3
San Diego 3
Dearborn 2
Lomé 2
Millbury 2
Munich 2
New York 2
Sacramento 2
Singapore 2
Varedo 2
Bremen 1
Edinburgh 1
Federal 1
Guidonia 1
Hangzhou 1
Hefei 1
Kochi 1
Lamporecchio 1
Laurel 1
Levallois-perret 1
Mahé 1
Mannheim 1
Nanjing 1
Sofia 1
Tallinn 1
Torino 1
Vigonza 1
Totale 437
Nome #
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 94
A phase II study of cetuximab/irinotecan in patients with heavily pretreated metastatic colorectal cancer: Predictive value of early specific toxicities 88
Neo-adjuvant and adjuvant chemotherapy in bladder cancer. 85
Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study. 85
Effectiveness and safety of an induction therapy with epoetin alfa in anemic cancer patients receiving concomitant chemotherapy 82
Adjuvant chemotherapy in esophageal cancer 51
Induction therapy before surgery for non-small cell lung cancer 39
Cost analysis of tumor-induced osteolysis treated with intravenous zoledronic acid and pamidronate: a time-motion study 35
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting 34
Real-World Outcomes of Trastuzumab Deruxtecan in Patients With HER2+ Metastatic Breast Cancer: The DE-REAL Study 17
DARPP-32 and t-DARPP in the development of resistance to anti-HER2 agents. Pre-clinical evidence from the STEP study 7
Totale 617
Categoria #
all - tutte 1.649
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.649


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020152 13 2 5 11 16 20 16 24 14 18 9 4
2020/202168 15 8 2 10 1 10 0 5 1 10 4 2
2021/202291 0 3 9 4 16 2 0 6 8 9 13 21
2022/2023114 20 35 9 4 12 10 4 5 10 0 4 1
2023/202452 1 7 0 4 5 4 0 1 4 9 11 6
2024/20253 3 0 0 0 0 0 0 0 0 0 0 0
Totale 617